Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Vargas Centanaro (MADRID, Spain), J. Rodriguez Hermosa (Madrid, Spain), J. Soriano (Madrid, Spain), J. López- Campos (Sevilla, Spain), J. Soler Cataluña (Valencia , Spain), J. Rodríguez Gonzalez Moro (Granada, Spain), B. Alcázar Navarrete (Madrid, Spain), M. Calle Rubio (Madrid, Spain). Factors associated with testing of COPD patients for serum AAT levels to detect cases of AATD. The EPOCONSUL study.. 570

Member's Comments

No comment yet.

Related content which might interest you: Analysis of serum prohepcidin and hepcidin levels in COPD patients by stages and by patient cathegory Source: Annual Congress 2013 –COPD treatment Year: 2013 Modified GAP index by including serum KL-6 to assess risk of disease progression in patients with interstitial lung diseases (ILD): preliminary results from the VAMOS study. Source: Virtual Congress 2021 – New approaches to diagnostic and prognostic evaluation of interstitial lung diseases of known causes Year: 2021 Stability of serum biomarkers and their associations with clinical outcomes in COPD patients and controls: a longitudinal study Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009 Alpha1-antitrypsin levels and phenotypes in COPD patients in Kyrgyz population Source: Annual Congress 2008 - Pathophysiology of COPD Year: 2008 Prevalence of alpha-1-antitrypsin deficiency (A1AD) in patients with COPD. Source: Virtual Congress 2021 – COPD burden, epidemiology and management Year: 2021 C-reactive protein serum levels, genotypes and the risk of COPD. The Rotterdam study Source: Annual Congress 2008 - Genetic risk factors for asthma and COPD Year: 2008 Longitudinal change of COPD assessment test (CAT) in a telehealthcare cohort is associated with exacerbation risk Source: International Congress 2017 – Current challenges in COPD evaluation Year: 2017 Association between alpha1 antitrypsin (AAT) circulating polymers (CP) and lung and liver disease in patients with AAT deficiency (AATD). Source: Virtual Congress 2021 – Molecular pathology and cell biology of pulmonary diseases Year: 2021 The results of alpha-1 antitrypsine (AAT) phenotyping in patients with COPD Source: Eur Respir J 2002; 20: Suppl. 38, 260s Year: 2002 Differences in the disease phenotype and comorbidities between patients with COPD and alpha-1-antitrypsin deficiency - An analysis of the COSYCONET cohort Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD Year: 2016 CT scan derived emphysema scores correlate with spirometry and gas exchange but not acute exacerbation rates (AER) or COPD assessment test (CAT) in COPD subjects with and without alpha-1-antitrypsin (AAT) deficiency Source: Annual Congress 2013 –Monitoring lung function in airway diseases Year: 2013 VEGF serum levels in COPD patients without pulmonary hypertension – a case control study Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Prevalence of alpha-1 antitrypsin deficiency (AATD) and frequencies of alleles PI*S and PI*Z in patients with COPD in Brazil Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population Year: 2013 Risk of cancer in individuals with severe alpha-1-antitrypsin deficiency (PiZZ) compared with the Swedish general population Source: Virtual Congress 2020 – Asthma and COPD: How genetic and environment influences its developement? Year: 2020 Follow-up of patients with uncontrolled asthma: clinical features of asthma patients according to the level of control achieved (the COAS study) Source: Eur Respir J , 49 (3) 1501885; DOI: 10.1183/13993003.01885-2015 Year: 2017 Serum TNFα, CD14 and CRP levels in COPD patients with different alpha-1 antitrypsin phenotypes Source: Annual Congress 2008 - Advances in functional genomics of neoplastic and non-neoplastic lung diseases Year: 2008 Characteristics of COPD patients and alpha-1 antitrypsin deficiency at outpatient respiratory clinics. The EPOCONSUL study. Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond Year: 2018 Clinical phenotype of individuals with common COPD investigated during the targeted detection programme for alpha1-antitrypsin deficiency in Italy Source: Annual Congress 2007 - Clinical aspects in COPD Year: 2007 Novel patterns of serum biomarkers profiling using minimal important clinical outcomes (MICO) in the longidutinal study BODE cohort of COPD patients Source: Annual Congress 2010 - COPD: symptoms and staging Year: 2010 Levels of YKL-40 in serum and sputum of patients diagnosed with hypersensitivity pneumonitis: A pilot study. Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis:  mechanistic insights and prognostic markers Year: 2018